All Pharma News
Relmada Therapeutics Provides Corporate Update

Relmada Therapeutics Provides Corporate Update
PR NEWSWIRE
04 Jan 2024
Share Share
Relmada Therapeutics to Present New Preclinical Data on its Psilocybin Program

Relmada Therapeutics to Present New Preclinical Data on its Psilocybin Program
PR NEWSWIRE
11 Oct 2023
Share Share
Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs

Relmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs
PR NEWSWIRE
06 Oct 2023
Share Share
Relmada’s major depression drug shows PhIII promise in a fresh batch of patients

Relmada’s major depression drug shows PhIII promise in a fresh batch of patients
Ayisha Sharma ENDPTS
21 Sep 2023
Share Share
Relmada to Participate in the 2023 Jefferies Global Healthcare Conference

Relmada to Participate in the 2023 Jefferies Global Healthcare Conference
PR NEWSWIRE
02 Jun 2023
Share Share
Relmada Therapeutics to Report 1Q 2023 FYR and Host Conference Call

Relmada Therapeutics to Report 1Q 2023 FYR and Host Conference Call
PR NEWSWIRE
08 May 2023
Share Share
After phase 3 flops, Relmada plots depression drug comeback

After phase 3 flops, Relmada plots depression drug comeback
Nick Paul Taylor FIERCE BIOTECH
25 Mar 2023
Share Share
Relmada Therapeutics to Report Fourth Quarter & Full-Year 2022 Financial Results

Relmada Therapeutics to Report Fourth Quarter & Full-Year 2022 Financial Results
PR NEWSWIRE
17 Mar 2023
Share Share
Relmada sinks further as depression drug fails second large trial

Relmada sinks further as depression drug fails second large trial
BIOPHARMADIVE
09 Dec 2022
Share Share
Relmada`s depression drug fails late-stage trial; shares crash

Relmada`s depression drug fails late-stage trial; shares crash
REUTERS
14 Oct 2022
Share Share